Send feedback

CHRNA3 p.Arg477Ser

c.1429C>A · rs751042207 · VCV2304521

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9939 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000254%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.9939likely pathogenic · top 5% in CHRNA3
REVEL0.875moderately pathogenic-leaning
SaProtLLR -14.50damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
PangolinΔ0.29loss · gain 0.02 · not in the SpliceAI release · independent
Constraint at this position
ConservationphyloP 8.6GERP -1.4, phastCons 1
Regional constrainto/e 0.85unconstrained · MANE · 24 kb · p 0.00014 · regional, not allelic
Overall
CADD26.8PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000254% European (non-Finnish) · 3/1,179,734 alleles
Filtering AF 6.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.9e-05%
Overall 0.000274% 4/1,460,464 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00156% 63,926
European (non-Finnish)grpmax 0.000254% 393,244

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CHRNA3
Protein
p.Arg477Ser
Coding
c.1429C>A
MANE Select
NM_000743
dbSNP
rs751042207
Type
single nucleotide variant
Location
chr15:78596693 (GRCh38)
Gene constraint
LOEUF 1.065 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.97 · 5 PDB
Residue 477
a UniProt-annotated variant site (in baiprck; loss-of-function variant affecting ion transmembrane transport in response to acetylcholine; does not localize to plasma membrane); an α-helix
Full CHRNA3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chrna3-p-arg477ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown